drugset / Trial / NCT00191542

Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents

NCT00191542

Phase 3 Completed 100 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

Comparison of the effect of Atomoxetine and psychoeducation with placebo and psychoeducation after 10 weeks of treatment

Timeline

Start
2005-03
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified